(Q34657373)

3 August 2017

0 references

1 reference

title

Health-related quality of life among persons with irritable bowel syndrome: a systematic review (English)

1 reference

3 August 2017

1 reference

1 reference

irritable bowel syndrome

1 reference

El-Serag HB

1

1 reference

3 August 2017

Olden K

series ordinal

2

1 reference

3 August 2017

Bjorkman D

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Alimentary Pharmacology & Therapeutics

3 August 2017

1 reference

3 August 2017

16

1 reference

3 August 2017

6

1 reference

3 August 2017

1171-1185

1 reference

Irritable bowel syndrome: a technical review for practice guideline development

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Quality of life measures in health care. I: Applications and issues in assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Psychologic and psychiatric aspects of gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Measurement of symptoms in irritable bowel syndrome clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

The quality of quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Quality of life measurement in gastroenterology: what is available?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Symptom and health-related quality-of-life measures for use in selected gastrointestinal disease studies: a review and synthesis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Bowel disorders impair functional status and quality of life in the elderly: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

The impact of irritable bowel syndrome on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Symptom differences in moderate to severe IBS patients based on predominant bowel habit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Health status by gastrointestinal diagnosis and abuse history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01290.X

10.1046/J.1365-2036.2002.01290.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference